Literature DB >> 17557686

No evidence that an exercise-based treatment programme (DDAT) has specific benefits for children with reading difficulties.

John P Rack1, Margaret J Snowling, Charles Hulme, Simon Gibbs.   

Abstract

Reynolds and Nicolson (Dyslexia: An International Journal of Research & Practice, 2007) report follow-up data 12 and 18 months after a period of intervention consisting of an exercise-based treatment programme (Dyslexia Dyspraxia Attention Treatment Programme, DDAT). The findings suggested the treatment had effects on bead threading, balance, rapid naming, semantic fluency and working memory but not on reading or spelling. We argue that the design of the study is flawed, the statistics used to analyse the data are inappropriate, and reiterate other issues raised by ourselves and others in this journal in 2003. Current evidence provides no support for the claim that DDAT is effective in improving children's literacy skills.

Entities:  

Mesh:

Year:  2007        PMID: 17557686     DOI: 10.1002/dys.335

Source DB:  PubMed          Journal:  Dyslexia        ISSN: 1076-9242


  4 in total

Review 1.  Cerebellar function in developmental dyslexia.

Authors:  Catherine J Stoodley; John F Stein
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

2.  Cerebellar function in children with and without dyslexia during single word processing.

Authors:  Sikoya M Ashburn; D Lynn Flowers; Eileen M Napoliello; Guinevere F Eden
Journal:  Hum Brain Mapp       Date:  2019-10-09       Impact factor: 5.038

3.  Persistent Childhood Primitive Reflex Reduction Effects on Cognitive, Sensorimotor, and Academic Performance in ADHD.

Authors:  Robert Melillo; Gerry Leisman; Raed Mualem; Alon Ornai; Eli Carmeli
Journal:  Front Public Health       Date:  2020-11-17

4.  Evaluating a new verbal working memory-balance program: a double-blind, randomized controlled trial study on Iranian children with dyslexia.

Authors:  Mehdi Ramezani; Saeed Behzadipour; Ehsan Pourghayoomi; Mohammad Taghi Joghataei; Elham Shirazi; Angela J Fawcett
Journal:  BMC Neurosci       Date:  2021-09-15       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.